Some thoughts on the reporting of adverse events in phase II cancer clinical trials.

Subjects

Subjects :

Clinical Trials, Phase II as Topic economics
Databases, Factual
Humans
National Institutes of Health (U.S.)
Publication Bias
Research Design
United States
Adverse Drug Reaction Reporting Systems standards
Antineoplastic Agents adverse effects
Neoplasms drug therapy
Product Surveillance, Postmarketing

Details

Language :

English

ISSN :

1527-7755

Volume :

24

Issue :

24

Database :

MEDLINE

Journal :

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Publication Type :

Report

Accession number :

16921032

Full Text :

https://doi.org/10.1200/JCO.2006.06.9856